Table 5.
Symptom correlations with vaginal metabolite concentrations showing differences in PVD NH compared to HC NH.
|
Vulvar vestibular pain total |
Total vaginal muscle tenderness |
||||
|---|---|---|---|---|---|
| Metabolites | Subpathway | R | P | r | p |
| Androstenediol (3beta,17beta) disulfate (1) | Androgenic Steroids | −0.50 | 0.01 | ||
| Androstenediol (3beta,17beta) disulfate (2) | Androgenic Steroids | −0.41 | 0.04 | ||
| Dehydroepiandrosterone sulfate (DHEA-S) | Androgenic Steroids | −0.64 | 0.0005 | −0.51 | 0.009 |
| Androsterone sulfate | Androgenic Steroids | −0.71 | 0.00007 | −0.48 | 0.02 |
Correlations were compute in PVD NH (N = 25). r: spearman’s rank correlation; p: probability value.